Relationship of plasma Dendroaspis natriuretic peptide-like immunoreactivity and echocardiographic parameters in chronic haemodialysis patients

Nephrology

Volumn 9, Issue 3, 2004, Pages 171-175

  Lee, Sik ^a   Park, Sung K ^a   Kang, Kyung P ^a   Kang, Sung K ^a   Kim, Sung Z ^a   Kim, Won ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Dendroaspis natriuretic peptide; Echocardiographic parameter; Haemodialysis

Indexed keywords

DENDROASPIS NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; SNAKE VENOM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FLOW RATE; HEART ATRIUM; HEART LEFT VENTRICLE; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; IMMUNOREACTIVITY; INFERIOR CAVA VEIN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SNAKE;

ADULT; AGED; ECHOCARDIOGRAPHY; ELAPID VENOMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; RENAL DIALYSIS;

EID: 3042707496     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00249.x     Document Type: Article

References (22)

1. Chen HH, Burnett Jr JC. The natriuretic peptides in heart failure: Diagnostic and therapeutic potentials. Proc. Assoc. Am. Physicians 1999; 111: 406-16.
2. Tonolo G, McMillan M, Polonia J et al. Plasma clearance and effects of alpha-hANP infused in patients with end-stage renal failure. Am. J. Physiol. 1988; 254: F895-9.
3. Buckley MG, Sethi D, Markandu ND et al. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin. Sci. 1992; 83: 437-44.
4. Katzarski KS, Randmaa I, Bergstrom J. Influence of hemodialysis on intravascular volume and vasoactive hormones. Clin. Nephrol. 1999; 52: 304-11.
5. Suda T, Osajima A, Iwamoto M et al. The mature form of adrenomedullin correlates with brain natriuretic peptide in plasma of chronic hemodialysis patients. Clin. Nephrol. 2002; 57: 444-51.
6. Nitta K, Kawashima A, Yumura W, Naruse M, Oba T, Kabaya T, Nihei H. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am. J. Nephrol. 1998; 18: 411-15.
7. Francesca M, Carmine Z, Giovanni T et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int. 2001; 59: 1559-66.
8. Sugihara K, Fujimoto S, Motomiya Y et al. Usefulness of long axis M-mode echocardiographic measurements for optimum dialysis in patients on maintenance hemodialysis: Comparison with changes in plasma levels of atrial natriuretic peptide and brain natriuretic peptide. Clin. Nephrol. 2001; 56: 140-9.
9. Toshio N, Yaouo F, Kolch T et al. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: Influence of coronary artery disease. Am. J. Kidney Dis. 2001; 37: 1201-8.
10. Schweitz H, Vigne P, Moinier D et al. A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J. Biol. Chem. 1992; 263: 13 928-32.
11. Ho PL, Soares MB, Maack T et al. Cloning of an unusual natriuretic peptide from the South American coral snake. Micrurus corallinus. Eur. J. Biochem. 1997; 250: 144-9.
12. Schirger JA, Heublein DM, Chen HH et al. Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure. Mayo Clin. Proc. 1999; 74: 126-30.
13. Fabrega E, Crespo J, Rivero M et al. Dendroaspis natriuretic peptide in hepatic cirrhosis. Am. J. Gastroenterol. 2001; 96: 2724-9.
14. Kim SW, Lee JU, Kim SZ, Choi KC, Kim NH, Cho KW. Enhanced Dendroaspis natriuretic peptide immunoreactivity in experimental ureteral obstruction. Nephron 2002; 92: 369-72.
15. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 1989; 2: 358-67.
16. Fatema K, Hirono O, Takeishi Y et al. Hemodialysis improves myocardial interstitial edema and left ventricular diastolic function in patients with end-stage renal disease: non-invasive assessment by ultrasonic tissue characterization. Heart Vessels 2002; 16: 227-31.
17. Cheriex EC, Leunissen KM, Janssen JH, Mooy JM, van Hooff JP. Echography of the inferior vena cava is a simple and reliable tool for estimation of 'dryweight' in haemodialysis patients. Nephrol. Dial. Transplant. 1989; 4: 563-8.
18. Krause I, Birk E, Davidovits M et al. Inferior vena cava diameter: A useful method for estimation of fluid status in children on haemodialysis. Nephrol. Dial. Transplant. 2001; 16: 1203-6.
19. Deray G, Maistre G, Cacoub P et al. Renal and hemodialysis clearances of endogenous natriuretic peptide. A clinical and experimental study. Nephron 1990; 54: 148-53.
20. Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. J. Clin. Endocrinol. Metab. 1986; 63: 819-22.
21. Morrisey C, Wilner KD, Barager RR, Ward DM, Ziegler MG. Atrial natriuretic factor in renal failure and posthemodialytic postural hypotension. Am. J. Kidney Dis. 1988; 12: 510-15.
22. Cataliotti A, Malatino LS, Jougasaki M et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin. Proc. 2001; 76: 1111-19.